These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22144422)

  • 21. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
    Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
    Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B
    PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history.
    Kastrinos F; Steyerberg EW; Mercado R; Balmaña J; Holter S; Gallinger S; Siegmund KD; Church JM; Jenkins MA; Lindor NM; Thibodeau SN; Burbidge LA; Wenstrup RJ; Syngal S
    Gastroenterology; 2011 Jan; 140(1):73-81. PubMed ID: 20727894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLH1-93G > A is a risk factor for MSI colorectal cancer.
    Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
    Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.
    Win AK; Young JP; Lindor NM; Tucker KM; Ahnen DJ; Young GP; Buchanan DD; Clendenning M; Giles GG; Winship I; Macrae FA; Goldblatt J; Southey MC; Arnold J; Thibodeau SN; Gunawardena SR; Bapat B; Baron JA; Casey G; Gallinger S; Le Marchand L; Newcomb PA; Haile RW; Hopper JL; Jenkins MA
    J Clin Oncol; 2012 Mar; 30(9):958-64. PubMed ID: 22331944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
    van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
    J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
    Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB
    J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer.
    Velayos FS; Lee SH; Qiu H; Dykes S; Yiu R; Terdiman JP; Garcia-Aguilar J
    J Gastrointest Surg; 2005 Mar; 9(3):329-35. PubMed ID: 15749592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
    Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
    Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of germline mutation of hMSH2, hMSH6 and hMLH1 and methylation of hMLH1 in microsatellite instability colorectal cancer].
    Ni M; Jin HY; Ding YJ; Liu F; Ding SQ; Fan ZM; Wang YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):358-61. PubMed ID: 18636359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation microsatellite path score in a population-based cohort of patients with colorectal cancer.
    Bessa X; Alenda C; Paya A; Álvarez C; Iglesias M; Seoane A; Dedeu JM; Abulí A; Ilzarbe L; Navarro G; Pellise M; Balaguer F; Castellvi-Bel S; Llor X; Castells A; Jover R; Andreu M
    J Clin Oncol; 2011 Sep; 29(25):3374-80. PubMed ID: 21788563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
    Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
    Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk.
    Gay LJ; Arends MJ; Mitrou PN; Bowman R; Ibrahim AE; Happerfield L; Luben R; McTaggart A; Ball RY; Rodwell SA
    Nutr Cancer; 2011; 63(7):1000-10. PubMed ID: 21875327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
    Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA
    J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
    Ashktorab H; Brim H; Al-Riyami M; Date A; Al-Mawaly K; Kashoub M; Al-Mjeni R; Smoot DT; Al-Moundhri M; Al-Hashemi S; Ganguly SS; Raeburn S
    Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer.
    Overbeek LI; Kets CM; Hebeda KM; Bodmer D; van der Looij E; Willems R; Goossens M; Arts N; Brunner HG; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Br J Cancer; 2007 May; 96(10):1605-12. PubMed ID: 17453009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease.
    Woods MO; Younghusband HB; Parfrey PS; Gallinger S; McLaughlin J; Dicks E; Stuckless S; Pollett A; Bapat B; Mrkonjic M; de la Chapelle A; Clendenning M; Thibodeau SN; Simms M; Dohey A; Williams P; Robb D; Searle C; Green JS; Green RC
    Gut; 2010 Oct; 59(10):1369-77. PubMed ID: 20682701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.